12:00 AM
Jul 15, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Trichuris suis ova: Completed Phase II enrollment

Coronado completed enrollment of 250 patients in the double-blind, placebo-controlled, U.S. Phase II TRUST-I trial evaluating 7,500 T. suis ova every 2 weeks for 12 weeks. The trial includes a 12-week open-label extension. Top-line data are slated for 4Q13. Dr. Falk Pharma is also evaluating...

Read the full 203 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >